Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1Phase 1/2 1

Status

Recruiting 2Unknown 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3UNKNOWN 1OTHER_GOV 1NETWORK 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 10184Triple Negative Breast Neoplasms 1046Neoplasms 574Ovarian Neoplasms 564Neoplasm Metastasis 515Colorectal Neoplasms 473Carcinoma, Non-Small-Cell Lung 468Prostatic Neoplasms 440Lung Neoplasms 433Pancreatic Neoplasms 312Melanoma 299Stomach Neoplasms 295Breast Neoplasms, Male 257Motor Activity 252Colonic Neoplasms 238Uterine Cervical Neoplasms 227Endometrial Neoplasms 223Head and Neck Neoplasms 218Carcinoma, Intraductal, Noninfiltrating 217Carcinoma, Renal Cell 192Squamous Cell Carcinoma of Head and Neck 181Sarcoma 177Urinary Bladder Neoplasms 159Esophageal Neoplasms 155Brain Neoplasms 155Breast Carcinoma In Situ 154Lymphedema 148Fatigue 136Carcinoma, Ovarian Epithelial 134Small Cell Lung Carcinoma 130

Interventions

palbociclib 1S 1 (combination) 1Re-Irradiation 1Docetaxel 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Breast Cancer Recurrent × Breast × Clear all
NCT07612254 2026-05-28

REPEAT

Dartmouth-Hitchcock Medical Center

Phase 1/2 Not yet recruiting
30 enrolled
Breast

Breast Cancer Recurrent

NCT03820830 2026-04-09

POLAR

ETOP IBCSG Partners Foundation

Phase 3 Active not recruiting
405 enrolled
Breast

Breast Cancer Recurrent

NCT05464082 2026-02-20

TOWARDS-II

University of Utah

Phase 2 Recruiting
80 enrolled
Breast

Breast Cancer Recurrent

NCT06458413 2024-06-13

Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer

Henan Cancer Hospital

Phase 2 Recruiting
40 enrolled
Breast

Breast Cancer Recurrent

NCT02947061 2016-10-31

S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer

ChineseAMS

Phase 2 Unknown
300 enrolled
Breast

Breast Cancer Recurrent

NCT01552655 2015-04-21

BREAC-AUT

Odense University Hospital

Phase NA Completed
101 enrolled
Breast

Breast Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡